Comparison Study for Bioelectrical Impedance Device to Measure Human Body Composition
NCT ID: NCT00956917
Last Updated: 2009-08-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
109 participants
INTERVENTIONAL
2009-05-31
2009-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Bioimpedance Body Composition Device Measurements
NCT01888068
Development of a Segmental Bioelectrical Impedance Spectroscopy Device for Body Composition Measurement
NCT04006899
Multi-frequency Bioelectrical Impedance for Estimating Total Body Water by Deuterium Dilution
NCT01607229
Neck-Worn Monitoring Sensor for - A Study for Monitoring Subjects With Fluid-Management Issues During Dialysis
NCT02140905
The Equivalency of the Imp SFB7+ (L-Dex U400) With the Imp XCA Device
NCT00766935
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Akern EFG
Akern USA EFG
Impedance measurement device
RJL device
RJL Impedance analyzer
Impedance analyzer
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Akern USA EFG
Impedance measurement device
RJL Impedance analyzer
Impedance analyzer
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
16 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Akern USA LLC
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Akern USA LLC
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Luca Gatteschi, MD
Role: PRINCIPAL_INVESTIGATOR
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Laboratorio, FIGC, Settore Tecnico Coverciano
D'Annunzio, Florence, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EFG001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.